GLP-1 (glucagon-like peptide 1) is a receptor agonist, a class of drugs originally designed to treat type 2 diabetes, with brand names such as Ozempic, Wegovy, and Mounjaro
Carbohydrates trigger an insulin response, which helps shuttle carnitine into the muscle cells
Lilly expects to share the study results at a diabetes conference and in a peer-reviewed medical journal later this year
Glucagon Thermogenesis GLP Diabetes Care 2023 View on PubMed GIP Receptor Agonism: Beyond Insulin Secretion to Adipose Tissue Remodeling Finding: GIP receptor (GIPR) activation was found to have direct effects on adipose tissue: improved fat storage efficiency (reduced ectopic fat), enhanced insulin sensitivity in adipocytes, and modulation of adipokine secretion (increased adiponectin, reduced resistin)
And there are more questions employers may be exploring with respect to covering GLP-1s for weight loss, such as: What about coverage for diabetics who are taking the medication already
How do you take Carnitin 3000